Th2 cytokines increase staphylococcus aureus alpha toxin-induced keratinocyte death through the signal transducer and activator of transcription 6 (STAT6)

Journal of Investigative Dermatology

Volumn 134, Issue 8, 2014, Pages 2114-2121

  Brauweiler, Anne M ^a   Goleva, Elena ^a   Leung, Donald Y M ^a  

^a DEPARTMENT OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHORYLCHOLINE; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; STAPHYLOCOCCUS ALPHA TOXIN; STAT6 PROTEIN;

ARTICLE; ATOPIC DERMATITIS; CELL DEATH; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; KERATINOCYTE; LAMELLAR BODY; LETHALITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN BIOPSY; STAPHYLOCOCCUS AUREUS; TH2 CELL;

BACTERIAL TOXINS; CELL DEATH; CELLS, CULTURED; CERAMIDES; CYTOKINES; DERMATITIS, ATOPIC; HEMOLYSIN PROTEINS; HUMANS; INTERLEUKIN-13; INTERLEUKIN-4; KERATINOCYTES; PHOSPHORYLCHOLINE; SPHINGOMYELIN PHOSPHODIESTERASE; STAT6 TRANSCRIPTION FACTOR; TH2 CELLS;

EID: 84904468226     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.43     Document Type: Article

References (36)

1. Albanesi C, Fairchild HR, Madonna S et al. (2007) IL-4 and IL-13 negatively regulate TNF-alpha-and IFN-gamma-induced beta-defensin expression through STAT-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3. J Immunol 179:984-92
2. Bieber T (2008) Atopic dermatitis. N Engl J Med 358:1483-94
3. Boguniewicz M, Leung DY (2011) Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 242:233-46
4. Brauweiler AM, Bin L, Kim BE et al. (2013) Filaggrin-dependent secretion of sphingomyelinase protects against staphylococcal alpha-toxin-induced keratinocyte death. J Allergy Clin Immunol 131:421-7. e1-2
5. Bubeck Wardenburg J, Bae T, Otto M et al. (2007) Poring over pores: alphahemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med 13:1405-6
6. De Benedetto A, Rafaels NM, McGirt LY et al. (2011) Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol 127:773-86. e1-7
7. Di Nardo A, Wertz P, Giannetti A et al. (1998) Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol 78:27-30
8. Elias PM, Wakefield JS (2011) Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis. Clin Rev Allergy Immunol 41:282-95
9. Gittler JK, Shemer A, Suarez-Farinas M et al. (2012) Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J Allergy Clin Immunol 130:1344-54
10. Grayson S, Johnson-Winegar AG, Wintroub BU et al. (1985) Lamellar bodyenriched fractions from neonatal mice: preparative techniques and partial characterization. J Invest Dermatol 85:289-94
11. Hamid Q, Boguniewicz M, Leung DY (1994) Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 94:870-6
12. Hatano Y, Terashi H, Arakawa S et al. (2005) Interleukin-4 suppresses the enhancement of ceramide synthesis and cutaneous permeability barrier functions induced by tumor necrosis factor-alpha and interferon-gamma in human epidermis. J Invest Dermatol 124:786-92
13. Howell MD, Kim BE, Gao P et al. (2007) Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 120:150-5
14. Janssens M, van Smeden J, Gooris GS et al. (2011) Lamellar lipid organization and ceramide composition in the stratum corneum of patients with atopic eczema. J Invest Dermatol 131:2136-8
15. Jensen JM, Folster-Holst R, Baranowsky A et al. (2004) Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. J Invest Dermatol 122:1423-31
16. Kim BE, Bin L, Ye YM et al. (2013) IL-25 enhances HSV-1 replication by inhibiting filaggrin expression, and acts synergistically with Th2 cytokines to enhance HSV-1 replication. J Invest Dermatol 133:2678-85
17. Kim BE, Leung DY, Boguniewicz M et al. (2008) Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6.
18. Kim MY, Linardic C, Obeid L et al. (1991) Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation. J Biol Chem 266:484-9
19. Klevens RM, Morrison MA, Nadle J et al. (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298: 1763-71
20. Kuo IH, Yoshida T, De Benedetto A et al. (2013) The cutaneous innate immune response in patients with atopic dermatitis. J Allergy Clin Immunol 131:266-78
21. McAleer MA, Irvine AD (2013) The multifunctional role of filaggrin in allergic skin disease. J Allergy Clin Immunol 131:280-91
22. Pilgram GS, Vissers DC, van der Meulen H et al. (2001) Aberrant lipid organization in stratum corneum of patients with atopic dermatitis and lamellar ichthyosis. J Invest Dermatol 117:710-7
23. Pillai S, Bikle DD, Hincenbergs M et al. (1988) Biochemical and morphological characterization of growth and differentiation of normal human neonatal keratinocytes in a serum-free medium. J Cell Physiol 134:229-37
24. Sawada E, Yoshida N, Sugiura A et al. (2012) Th1 cytokines accentuate but Th2 cytokines attenuate ceramide production in the stratum corneum of human epidermal equivalents: An implication for the disrupted barrier mechanism in atopic dermatitis. J Dermatol Sci 68: 25-35
25. Schwiering M, Brack A, Stork R et al. (2013) Lipid and phase specificity of alpha-toxin from S. aureus. Biochim Biophys Acta 1828:1962-72
26. Suarez-Farinas M, Dhingra N, Gittler J et al. (2013) Intrinsic atopic dermatitis shows similar TH2 and higher T17 immune activation compared with extrinsic atopic dermatitis. J Allergy Clin Immunol 132: 361-70
27. Taubler JH, Kapral FA, Mudd S (1963) Role of alpha-toxin in lesion formation by Staphylococcus aureus on sutures subcutaneously implanted in mice. J Bacteriol 86:51-7
28. Travagli J, Letourneur M, Bertoglio J et al. (2004) STAT6 and Ets-1 form a stable complex that modulates Socs-1 expression by interleukin-4 in keratinocytes. J Biol Chem 279:35183-92
29. Travers JB, Norris DA, Leung DY (2001) The keratinocyte as a target for staphylococcal bacterial toxins. J Investig Dermatol Symp Proc 6: 225-30
30. Uchida Y, Murata S, Schmuth M et al. (2002) Glucosylceramide synthesis and synthase expression protect against ceramide-induced stress. J Lipid Res 43:1293-302
31. Valeva A, Hellmann N, Walev I et al. (2006) Evidence that clustered phosphocholine head groups serve as sites for binding and assembly of an oligomeric protein pore. J Biol Chem 281:26014-21
32. Valeva A, Walev I, Pinkernell M et al. (1997) Transmembrane beta-barrel of staphylococcal alpha-toxin forms in sensitive but not in resistant cells. Proc Natl Acad Sci USA 94:11607-11
33. Watanabe M, Tomita T, Yasuda T (1987) Membrane-damaging action of staphylococcal alpha-toxin on phospholipid-cholesterol liposomes. Biochim Biophys Acta 898:257-65
34. Wertz PW, Downing DT, Freinkel RK et al. (1984) Sphingolipids of the stratum corneum and lamellar granules of fetal rat epidermis. J Invest Dermatol 83:193-5
35. Wichmann K, Uter W, Weiss J et al. (2009) Isolation of alpha-toxin-producing Staphylococcus aureus from the skin of highly sensitized adult patients with severe atopic dermatitis. Br J Dermatol 161:300-5
36. Wilke GA, Bubeck Wardenburg J (2010) Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus alpha-hemolysin-mediated cellular injury. Proc Natl Acad Sci USA 107:13473-8